The pharmaceutical industry, grappling with new government limits on drug prices, is focusing its requests for ...
From 2017 to 2022, the companies marked up prices at their pharmacies by hundreds or thousands of percent, netting them $7.3 ...
The U.S. Federal Trade Commission (FTC) has slammed pharmacy benefit managers (PBMs) owned by UnitedHealth ($UNH), CVS Health ...
Units of CVS Health Corp., Cigna Group and UnitedHealth Group Inc. charged significantly more than the national average ...
FTC report reveals significant markups by top PBMs on specialty drugs, driving $7.3 billion in revenue and raising costs for ...
Regulators published their most detailed findings yet on how some of the nation’s largest companies profited from "excess" ...
The nation's three largest pharmacy benefit managers have significantly marked up the prices of certain medicines, including ...
CVS’ efforts to reform how its pharmacies are paid have reached a significant milestone that should stabilize flagging ...
Cigna (CI) and UnitedHealth (UNH) significantly marked up prices for specialty generic drugs over a six-year period.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback